Recombinant Pantoea vagans Protein AaeX (aaeX)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them when placing your order, and we will accommodate your request.
Lead Time
Delivery time may vary depending on the purchase method or location. Please consult your local distributors for specific delivery times.
Note: All our proteins are shipped with standard blue ice packs. If dry ice shipment is required, please communicate with us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle at the bottom. Please reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard final glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life is influenced by factors such as storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production. If you have a specific tag type preference, please inform us, and we will prioritize developing the specified tag.
Synonyms
aaeX; Pvag_2816; Protein AaeX
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-67
Protein Length
full length protein
Species
Pantoea vagans (strain C9-1) (Pantoea agglomerans (strain C9-1))
Target Names
aaeX
Target Protein Sequence
MSVLPVFVMFGLSFPPVFIELIISLMLFWLVKRVLTPSGIYDLVWHPALFNTALYCCVFY LVSRLLV
Uniprot No.

Target Background

Database Links
Protein Families
AaeX family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is the molecular structure and function of Recombinant Pantoea vagans Protein AaeX?

Recombinant Pantoea vagans Protein AaeX (aaeX) is a membrane protein derived from Pantoea vagans strain C9-1 (previously classified as Pantoea agglomerans strain C9-1). The protein consists of 67 amino acids with the sequence: MSVLPVFVMFGLSFPPVFIELIISLMLFWLVKRVLTPSGIYDLVWHPALFNTALYCCVFYLVSRLLV . The protein has a UniProt accession number E1SFM6 and appears to function as a transmembrane protein, though its specific cellular role remains under investigation.

The hydrophobic amino acid composition suggests it contains membrane-spanning domains, with the predominance of leucine, valine, and phenylalanine residues indicating potential membrane integration. Current structural studies indicate it likely adopts an alpha-helical conformation within bacterial membranes, typical of many bacterial membrane transport proteins.

What expression systems are most effective for producing Recombinant Pantoea vagans Protein AaeX?

For optimal expression of Recombinant Pantoea vagans Protein AaeX, researchers should consider:

  • E. coli-based systems: Most commonly used for initial expression trials, particularly BL21(DE3) or Rosetta strains for membrane proteins. Codon optimization may be necessary as Pantoea and E. coli have different codon usage patterns.

  • Cell-free expression systems: These can be advantageous for membrane proteins like AaeX that may be toxic to host cells when overexpressed.

  • Yeast expression systems: Pichia pastoris or Saccharomyces cerevisiae can provide eukaryotic post-translational modifications if needed.

The expression methodology should include:

  • Cloning the aaeX gene into an appropriate vector with a strong, inducible promoter

  • Incorporating affinity tags (His6, GST, or FLAG) to facilitate purification

  • Optimizing induction conditions (temperature, inducer concentration, and duration)

  • Implementing proper membrane protein extraction protocols using mild detergents

What purification strategies yield the highest purity for Recombinant Pantoea vagans Protein AaeX?

A multi-step purification strategy is recommended for obtaining high-purity Recombinant Pantoea vagans Protein AaeX:

Step 1: Initial Extraction

  • Solubilize membrane fractions using appropriate detergents (e.g., n-dodecyl-β-D-maltoside or CHAPS)

  • Centrifuge at >100,000×g to remove insoluble material

Step 2: Primary Purification

  • Apply ion-exchange chromatography (IEX) as an initial capture step, which remains one of the most effective methods for initial protein separation

  • For AaeX, a strong anion exchanger is recommended at pH 7.5-8.0 based on its predicted isoelectric point

  • Elute using a gradient of increasing ionic strength (typically 0-500 mM NaCl)

Step 3: Secondary Purification

  • Implement affinity chromatography using the incorporated tag (if applicable)

  • Follow with size exclusion chromatography to remove aggregates and achieve final polishing

Step 4: Quality Control

  • Confirm purity via SDS-PAGE (≥95% homogeneity)

  • Verify identity through Western blotting and/or mass spectrometry

This multi-step approach typically yields protein with >95% purity suitable for structural and functional studies.

What analytical methods are recommended for characterizing Recombinant Pantoea vagans Protein AaeX?

Comprehensive characterization of Recombinant Pantoea vagans Protein AaeX should include:

Primary Structure Analysis

  • MS/MS peptide mapping to confirm sequence identity

  • N-terminal sequencing to verify correct processing

Secondary Structure Analysis

  • Circular dichroism (CD) spectroscopy to determine α-helical content

  • FTIR spectroscopy for complementary secondary structure information

Tertiary Structure

  • NMR spectroscopy for solution structure (challenging for membrane proteins)

  • X-ray crystallography if crystals can be obtained

Functional Characterization

  • Liposome reconstitution assays to evaluate membrane integration

  • Binding assays with potential interacting partners

Stability Assessment

  • Differential scanning calorimetry to determine thermal stability

  • Storage stability tests at various conditions (-20°C, -80°C with 50% glycerol)

Table 1: Recommended Characterization Methods for Recombinant AaeX Protein

Analysis TypeMethodInformation ObtainedSample Requirements
IdentityMS/MSSequence confirmation10-50 μg, high purity
StructureCD SpectroscopySecondary structure0.1-0.5 mg/mL, >90% pure
FunctionLiposome AssaysMembrane integration100-200 μg, active protein
StabilityThermal ShiftThermal stability (Tm)50-100 μg, >85% pure

How can Design of Experiment (DoE) approaches be applied to optimize Recombinant Pantoea vagans Protein AaeX production?

Implementing DoE methodologies can significantly enhance recombinant AaeX production by identifying optimal conditions while minimizing experimental runs:

Step 1: Identify Critical Process Parameters (CPPs)

  • Expression temperature (typically 16-37°C)

  • Inducer concentration (e.g., IPTG 0.1-1.0 mM)

  • Post-induction time (4-24 hours)

  • Media composition (standard vs. enriched)

  • Cell density at induction (OD600 0.4-1.0)

Step 2: Design Factorial Experiments

  • Implement a full or fractional factorial design to screen factors

  • For example, a 2³ factorial design examining temperature, inducer concentration, and induction time would require 8 experimental conditions

Step 3: Analysis and Optimization

  • Analyze results using statistical software (e.g., JMP, Minitab)

  • Generate response surface models to identify optimal conditions

  • Validate optimized conditions with confirmation runs

This DoE approach has been successfully applied to similar recombinant protein production systems, as demonstrated in the AAV particle enrichment study . For membrane proteins like AaeX, this approach is particularly valuable for balancing expression level with proper folding.

What strategies can resolve data inconsistencies in Recombinant Pantoea vagans Protein AaeX research?

When encountering data inconsistencies in AaeX research, implement the following systematic approach:

Step 1: Data Validation and Exploratory Analysis

  • Apply exploratory data analysis techniques to identify patterns and outliers5

  • Use histogram and box plot analysis to visualize data distribution

  • Implement statistical tests to identify significant deviations

Step 2: Experimental Variable Control

  • Standardize protein batches using validated quantification methods

  • Implement strict temperature and pH control during experiments

  • Document detailed reagent sources and lot numbers

Step 3: Methodological Validation

  • Perform method validation studies including:

    • Precision (intra-assay and inter-assay variability)

    • Accuracy (recovery tests)

    • Linearity (response across concentration ranges)

    • Specificity (cross-reactivity assessments)

Step 4: Inter-laboratory Verification

  • When possible, verify critical findings through collaborative studies

  • Implement blinded sample analysis to minimize bias

Table 2: Common Sources of Inconsistency in AaeX Research and Mitigation Strategies

Source of InconsistencyDetection MethodMitigation Strategy
Protein heterogeneitySDS-PAGE, SEC-MALSOptimize purification protocol
Detergent effectsFunctional assays with different detergentsStandardize detergent type and concentration
Buffer compositionpH/conductivity monitoringPrepare fresh buffers, validate components
Instrument variabilityRegular calibration checksImplement system suitability tests

How can researchers troubleshoot low yields of Recombinant Pantoea vagans Protein AaeX?

Low yields of Recombinant Pantoea vagans Protein AaeX can be systematically addressed through the following troubleshooting workflow:

Expression Issues

  • Verify vector construction through sequencing

  • Test multiple expression strains (BL21, C41/C43 for membrane proteins)

  • Optimize codon usage for the expression host

  • Reduce expression temperature to 16-20°C to improve folding

  • Evaluate different induction strategies (IPTG concentration, induction timing)

Extraction Efficiency

  • Screen multiple detergents (DDM, LDAO, Fos-choline)

  • Optimize detergent-to-protein ratio

  • Extend solubilization time (4-16 hours)

  • Test different buffer compositions (pH 6.5-8.5)

Purification Recovery

  • Implement mild wash conditions during affinity chromatography

  • Use gradient elution for ion exchange chromatography

  • Minimize concentration steps to prevent aggregation

  • Add stabilizing agents (glycerol, specific lipids)

Storage and Handling

  • Store protein in Tris-based buffer with 50% glycerol at -20°C or -80°C

  • Avoid repeated freeze-thaw cycles

  • Add protease inhibitors to prevent degradation

This systematic approach typically improves yields by 2-5 fold compared to standard protocols.

What are the recommended approaches for studying Pantoea vagans Protein AaeX interaction with lipopolysaccharides?

To investigate potential interactions between Recombinant Pantoea vagans Protein AaeX and lipopolysaccharides (LPS), consider these methodological approaches:

In Vitro Binding Studies

  • Surface Plasmon Resonance (SPR)

    • Immobilize purified AaeX on a sensor chip

    • Flow purified LPS over the surface at various concentrations

    • Determine binding kinetics (kon, koff) and affinity (KD)

  • Microscale Thermophoresis (MST)

    • Label either AaeX or LPS with a fluorescent dye

    • Measure changes in thermophoretic mobility upon binding

    • Calculate binding parameters in near-native solution conditions

Functional Reconstitution

  • Liposome Co-reconstitution

    • Incorporate AaeX and LPS into synthetic liposomes

    • Measure changes in membrane properties or permeability

    • Compare with control liposomes lacking either component

  • Membrane Model Systems

    • Use supported lipid bilayers containing AaeX

    • Visualize interactions with LPS using atomic force microscopy

Cellular Models

  • Heterologous Expression Systems

    • Express AaeX in cells with varying LPS compositions

    • Assess impact on cell membrane properties and integrity

    • This approach is particularly relevant given the role of Pantoea agglomerans LPS in bone density maintenance

What emerging technologies can advance structural studies of Recombinant Pantoea vagans Protein AaeX?

Several cutting-edge technologies are particularly promising for advancing structural understanding of membrane proteins like AaeX:

Cryo-Electron Microscopy (Cryo-EM)

  • Single-particle analysis for high-resolution structures without crystallization

  • Ideal for membrane proteins that resist crystallization

  • Can reveal dynamic conformational states

Integrative Structural Biology

  • Combining multiple techniques (NMR, SAXS, computational modeling)

  • Allows for structure determination in near-native environments

  • Particularly valuable for membrane proteins like AaeX

Advanced Computational Methods

  • AlphaFold2 and RoseTTAFold for accurate structure prediction

  • Molecular dynamics simulations to study membrane integration

  • Predicted AaeX structures can guide experimental design

Native Mass Spectrometry

  • Analyzes intact membrane protein complexes

  • Reveals protein-lipid interactions

  • Maintains native protein fold during analysis

Lipid Nanodisc Technology

  • Incorporates AaeX into defined lipid environments

  • Enables solution-state structural studies

  • Provides a more native-like environment than detergent micelles

These emerging approaches can overcome traditional challenges in membrane protein structural biology and provide unprecedented insights into AaeX structure-function relationships.

How can high-throughput approaches accelerate functional characterization of Recombinant Pantoea vagans Protein AaeX?

High-throughput methodologies can dramatically accelerate functional characterization of AaeX through parallel experimentation and automated analysis:

Multiplexed Expression Screening

  • Test multiple constructs, tags, and expression conditions simultaneously

  • Use fluorescent reporters to monitor expression levels

  • Implement automated cell lysis and protein detection

Automated Purification Platforms

  • Develop parallelized chromatography workflows

  • Implement liquid handling robotics for consistent processing

  • Use technologies like the Stunner® for rapid analysis of multiple samples simultaneously

Functional Microarrays

  • Immobilize AaeX variants on microarray surfaces

  • Screen for interactions with multiple potential binding partners

  • Analyze binding profiles across thousands of conditions

High-Content Imaging

  • Express fluorescently tagged AaeX in cellular models

  • Track localization, trafficking, and interactions

  • Quantify phenotypic changes following genetic or chemical perturbations

Parallel Activity Assays

  • Design 96- or 384-well compatible assays for AaeX function

  • Screen across multiple conditions simultaneously

  • Implement appropriate controls for statistical validation

Table 3: Comparison of High-Throughput Methods for AaeX Characterization

MethodThroughputSample RequirementKey AdvantageLimitation
Stunner® Analysis96 samples/70 min2 μL/sampleSimultaneous UV-Vis, DLS, SLS analysisSpecialized equipment required
Microfluidic Assays>1000 conditions/day<1 μL/conditionMinimal sample consumptionMethod development complexity
Automated Chromatography8-24 samples/day1-5 mg proteinConsistent purificationHigher protein requirements
Biolayer Interferometry96 samples/run50-100 μg proteinReal-time binding analysisSurface immobilization artifacts

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.